Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 CHF | -0.15% | -5.73% | -1.89% |
Mar. 15 | Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024 | |
Mar. 15 | Molecular Partners Swings to Loss in FY23; Revenue Down | MT |
Sales 2024 * | 25.04M 27.49M | Sales 2025 * | 7.5M 8.24M | Capitalization | 111M 122M |
---|---|---|---|---|---|
Net income 2024 * | -47M -51.61M | Net income 2025 * | -69M -75.76M | EV / Sales 2024 * | 4.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 14.8 x |
P/E ratio 2024 * |
-2.52
x | P/E ratio 2025 * |
-1.6
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.11% |
Latest transcript on Molecular Partners AG
1 day | -0.30% | ||
1 week | -5.73% | ||
Current month | -8.16% | ||
1 month | -1.03% | ||
3 months | -17.78% | ||
6 months | -3.02% | ||
Current year | -1.89% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 52 | 04-11-22 | |
Patrick Amstutz
FOU | Founder | 49 | 04-11-22 |
Michael Pitzner
CMP | Compliance Officer | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Burns
CHM | Chairman | 76 | 17-10-30 |
Steven Holtzman
BRD | Director/Board Member | 70 | 14-09-18 |
Vito Palombella
BRD | Director/Board Member | 61 | 20-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 3.375 | -0.15% | 9 847 |
24-04-16 | 3.38 | -5.45% | 4,750 |
24-04-15 | 3.575 | +0.99% | 4,518 |
24-04-12 | 3.54 | +1.14% | 21,911 |
24-04-11 | 3.5 | -2.23% | 8,657 |
Delayed Quote Swiss Exchange, April 17, 2024 at 11:31 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.89% | 122M | |
-3.30% | 102B | |
+3.32% | 96.09B | |
-1.02% | 22.05B | |
-18.31% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.13% | 14.01B | |
+1.45% | 13.38B | |
+22.70% | 11.01B |
- Stock Market
- Equities
- MOLN Stock